Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by bartlmanon Jul 11, 2016 12:16am

166 Views

Post# 25040001

In my humble opinion

they should have submitted the device as disposable. They would have needed, what, 4 separate units?, with which to begin preliminary human testing. While human testing was on-going, they could have gone pushed on with additional hygenic testing and development on the non-disposable, reusable version and a secondary ITA.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!